Equalize Health Launches $15M Fund for Maternal an...
The $15M Catalytic Fund will provide healthcare and world-class medical technologies to five million patients by 2025 and help end the leading causes of preventable maternal and newborn deaths.
The Pulse - our central platform for latest news and perspectives.
Consider it your lifeline for internal developments at Equalize Health and important global health and innovation news.
The $15M Catalytic Fund will provide healthcare and world-class medical technologies to five million patients by 2025 and help end the leading causes of preventable maternal and newborn deaths.
Equalize Health CEO, Krista Donaldson, is a 2021 Elevate Prize winner.
Charity Navigator awards Equalize Health a coveted 4-out-of-4-star rating for sound fiscal management, accountability, and transparency.
Equalize Health has received a generous donation in memory of Kip Freshwater, a captivating 5-year old boy from Birmingham, England, to support the final development of FlowLite.
A partnership to develop and launch a mother-centered, “blood loss monitoring device” to detect PPH, the leading cause of maternal death globally.